Washington, July 9 -- Congressman Kevin Mullin issued the following press release:
To prevent unnecessary delays in the development of potentially lifesaving medications and medical devices during a government shutdown, Rep. Kevin Mullin (CA-15) introduced the Getting Innovations to Patients During Shutdowns Act.
This legislation would ensure the Food and Drug Administration (FDA) can continue reviewing applications for new drugs and medical devices even if there is a lapse in government funding - a so-called government shutdown. The bill was inspired by a company based in Rep. Mullin's district that was working on a rare disease treatment that became stalled as a result of the most recent, and longest in U.S. history, shutdown in October...